ConductScience.org, home

Paper40134277

Immunotherapy for hypertensive end-organ damage: a new therapeutic strategy.

Xu Z and 3 others. Essays Biochem, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Immunotherapy for hypertensive end-organ damage: a new therapeutic strategy. Papers, record 40134277. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40134277

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Immunotherapy for hypertensive end-organ damage: a new therapeutic strategy.
PubMed
Journal
Essays Biochem
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2026-05-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xu ZZhiyang
2Yu HHaisheng
3Zhuang RRulinhttps://orcid.org/0000-0003-4557-4289
4Fan QQinhttps://orcid.org/0000-0002-6018-0889

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HypertensionMajor topic
ImmunotherapyMajor topic
Humans
Animals

References102

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138882290Role of plasmacytoid dendritic cells in vascular dysfunction in mice with renovascular hypertension.Heliyon2024https://conductscience.org/library/papers/38882290PubMed
229378857Myeloid CD11c+ Antigen-Presenting Cells Ablation Prevents Hypertension in Response to Angiotensin II Plus High-Salt Diet.Hypertension2018https://conductscience.org/library/papers/29378857PubMed
317143175A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.J Hypertens2007https://conductscience.org/library/papers/17143175PubMed
417938380Chemokine receptor 2b inhibition provides renal protection in angiotensin II - salt hypertension.Hypertension2007https://conductscience.org/library/papers/17938380PubMed
521224080Natural regulatory T cells control coronary arteriolar endothelial dysfunction in hypertensive mice.Am J Pathol2011https://conductscience.org/library/papers/21224080PubMed
638778172Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues.Hypertens Res2024https://conductscience.org/library/papers/38778172PubMed
733488583Combination Treatment With Metformin and Tacrolimus Improves Systemic Immune Cellular Homeostasis by Modulating Treg and Th17 Imbalance.Front Immunol2020https://conductscience.org/library/papers/33488583PubMed
835704473Update on Immune Mechanisms in Hypertension.Am J Hypertens2022https://conductscience.org/library/papers/35704473PubMed
937664577A new immune disease: systemic hypertension.Clin Kidney J2023https://conductscience.org/library/papers/37664577PubMed
1038545112Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy.Front Immunol2024https://conductscience.org/library/papers/38545112PubMed
1138047378CD4+ T-Cell Legumain Deficiency Attenuates Hypertensive Damage via Preservation of TRAF6.Circ Res2024https://conductscience.org/library/papers/38047378PubMed
1238483840Particle-Based Artificial Antigen-Presenting Cell Systems for T Cell Activation in Adoptive T Cell Therapy.ACS Nano2024https://conductscience.org/library/papers/38483840PubMed
1336958796Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial.Ann Rheum Dis2023https://conductscience.org/library/papers/36958796PubMed
1421817097Interleukin-10 released by CD4(+)CD25(+) natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice.Arterioscler Thromb Vasc Biol2011https://conductscience.org/library/papers/21817097PubMed
1533868284Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.Front Immunol2021https://conductscience.org/library/papers/33868284PubMed
1629969833Hypertension: a new treatment for an old disease? Targeting the immune system.Br J Pharmacol2019https://conductscience.org/library/papers/29969833PubMed
177068177The mosaic theory 32 years later.Hypertension1982https://conductscience.org/library/papers/7068177PubMed
1835998751Endoplasmic reticulum stress: A common pharmacologic target of cardioprotective drugs.Eur J Pharmacol2022https://conductscience.org/library/papers/35998751PubMed
1938821150The current landscape of antifibrotic therapy across different organs: A systematic approach.Pharmacol Res2024https://conductscience.org/library/papers/38821150PubMed
2038686582Immunomodulatory Activity of Cytokines in Hypertension: A Vascular Perspective.Hypertension2024https://conductscience.org/library/papers/38686582PubMed

See all 102 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41155215Immunology of Hypertension: Pathophysiological and Therapeutic Aspects.Int J Mol Sci2025https://conductscience.org/library/papers/41155215PubMed
40922600Immunomodulation: precision targeting for restoring immune homeostasis and therapeutic applications.Essays Biochem2025https://conductscience.org/library/papers/40922600PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40134277

GET https://conductscience.org/api/papers/v1/40134277/references?page=2